Companies › AMAG Pharmaceuticals
1 active drug program in 11 registered trials: 4 Phase 3, 4 Phase 2, 2 Phase 1, 1 Phase 4; Neurology, Cardiovascular, Genitourinary, Hematology.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| Ferumoxytol Iron replacement therapy - iron oxide nanoparticles coated with polyglucose sorbitol carbo | – | Phase 3 | Iron Deficiency Anemia; Chronic Kidney Disease; Iron Deficiency Anemia; Pregnancy Related; Glioblastoma … | – |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT04268849 | Ferumoxytol | Phase 3 | Iron Deficiency Anemia | Hematology | Nov 2025 |
| NCT03893045 | Ferumoxytol | Phase 3 | Iron Deficiency Anemia | Hematology | Jul 2026 |
| NCT07452250 | Ferumoxytol | Phase 2 | Venous Diseases | Cardiovascular | Aug 2026 |
| NCT03619850 | Ferumoxytol | Phase 3 | Chronic Kidney Disease; Iron Deficiency Anemia | Genitourinary | Aug 2026 |
| NCT04278651 | Ferumoxytol | Phase 4 | Pregnancy Related | Hematology | Dec 2026 |
| NCT04900792 | Ferumoxytol | Phase 1 | Glioblastoma | Oncology | Dec 2026 |
| NCT05340465 | Ferumoxytol | Phase 2 | Prematurity | Hematology | Jan 2027 |
| NCT06440408 | Ferumoxytol | Phase 1 | Pulmonary Vein Stenosis | Cardiovascular | Jun 2027 |
| NCT03270059 | Ferumoxytol | Phase 2 | Central Nervous System Neoplasm | Oncology | Dec 2027 |
| NCT07461948 | Ferumoxytol | Phase 3 | Glioblastoma | Oncology | Oct 2028 |
| NCT06483061 | Ferumoxytol | Phase 2 | Epilepsy, Temporal Lobe | Neurology | Sep 2029 |
No annotated target.
–
Ablative Solutions Mercator MedSystems THPharm Kissei Pharmaceutical Shenzhen Ausa Pharmed
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.